Algemeen Ziekenhuis Delta

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alopecia areata1 trial
• Lung cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• AbbVie1 trial
• European Organisation for Research and Treatment of Cancer - EORTC1 trial
• OSE Immunotherapeutics1 trial

Running trials

• Recruiting

  Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

  NCT05974774· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source

• Recruiting

  A phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) after immunotherapy failure.

  2023-509340-10-00· Phase 3· OSE Immunotherapeutics· Source

• Recruiting

  A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

  NCT06012240· Phase 3· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Prostate cancer1 recruiting